Monoclonal Antibody Discovery & Antibody Development

We develop novel monoclonal antibodies for the pharmaceutical industry and academia as highly specialized therapeutics, diagnostics, or impactful research tools in biomedical research.

MABY is a spin-off company from the Biomedical Sciences Research Center (BSRC) “A. Fleming”

Intellectual Property Protection

Customized to Work in Your Assay

Our Founders are Experts in Neuroimmunology & Neurobiology

Contact